Percutaneous imaging-guided radiofrequency ablation in patients with colorectal pulmonary metastases: 1-year follow-up

Percutaneous imaging-guided radiofrequency ablation in patients with colorectal pulmonary metastases: 1-year follow-up
复制标题

DOI:
10.1245/aso.2004.04.008
复制
发表时间:
2004-02-01
影响因子:
3.7
通讯作者:
Morris, DL
Morris, DL
中科院分区:
医学2区
文献类型:
--
作者:
Steinke, K;Glenn, D;Morris, DL

文献摘要

被引文献

相似文献

背景资料:我们评估的安全性和证据的有效性,射频消融(RFA)的结直肠癌肺转移瘤随访1 year.Methods:23例患者经皮射频消融52结直肠癌肺转移瘤下的荧光计算机断层扫描(CT)。患者接受静脉清醒镇静和局部镇痛,常规住院,并在RFA后24小时进行监测。术后1个月及以后每3个月复查CT,每月及每3个月复查血清癌胚抗原。肿瘤直径范围为0.3至4.2 cm。43%(10/23)的患者发生气胸。6名患者需要肋间胸腔引流管放置。6例患者接受了第二次RFA,4例为新发病变,2例为既往治疗病变的再次治疗。中位住院时间为2.0天(范围:1-9天)。中位随访时间为428天(范围:173-829天);本文报告的数据为1年。5例患者在RFA后5、6、8、8和12个月死于肺外(n = 1)或广泛(n = 4)疾病。1例患者在RFA后6个月发生恶性胸腔积液。在9处治疗病变(17%)中观察到空洞;所有病变均在12个月时消退,瘢痕组织收缩。18例患者在7年时进行CT扫描随访,有40个病灶被分类为消失(n = 17),缩小(n = 5),稳定/相同大小(n = 4),或增加(n = 14)。结论:经皮成像引导RFA多发结直肠肺转移瘤是一种微创治疗选择,发病率适中。相当大比例的患者在1年时显示出成功局部控制的良好证据。
Background: We assessed the safety and evidence of efficacy of radiofrequency ablation (RFA) for colorectal lung metastases with follow-up to 1 year.Methods: Twenty-three patients had percutaneous RFA for 52 colorectal pulmonary metastases under fluoro-computed tomography (CT). Patients received intravenous conscious sedation and local analgesia with routine hospitalization and monitoring for 24 hours after RFA. Patients had CT scanning at 1 month and then every 3 months, with serum carcinoembryonic antigen assessment monthly and every 3 months.Results: All ablations were technically successful. Tumor diameter ranged from .3 to 4.2 cm. Pneumothorax occurred in 43% (10 of 23) of patients. Six patients required intercostal chest drain placement. Six patients had a second RFA, four for new lesions and two for re-treatment of a previously treated lesion. The median admission was 2.0 days (range, 1-9 days). The median follow-up was 428 days (range, 173-829 days); data are reported to 1 year in this article. Five patients died at 5, 6, 8, 8, and 12 months after RFA from extrapulmonary (n = 1) or widespread (n = 4) disease. One patient developed a malignant pleural effusion at 6 months after RFA. Cavitation was seen in nine treated lesions (17%); all resolved with scar tissue contraction by 12 months. Eighteen patients with CT scan follow-up at 7 year have 40 lesions classified as disappeared (n = 17), decreased (n = 5), stable/same size (n = 4), or increased (n = 14).Conclusions: Percutaneous imaging-guided RFA of multiple colorectal pulmonary metastases is a minimally invasive treatment option with modest morbidity. A significant proportion of patients show good evidence of successful local control at 1 year.